clinical trial · NCT07422298
A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants
Bristol-Myers Squibb·phase1·recruiting·n = 32
Healthy VolunteersBMS-986278PlaceboMoxifloxacin
brief summary
The purpose of this study is to evaluate the effect of BMS-986278 on the cardiac repolarization in healthy participants.
started
Feb 19, 2026
primary completion
Jun 15, 2026
completion
Jun 15, 2026
last updated
Mar 17, 2026
official title
A Phase 1, Randomized, Double-blind, Positive-controlled, Placebo-controlled, 4-Period Crossover, Thorough QT/QTc Study to Evaluate the Effect of Multiple Doses of BMS-986278 on Cardiac Repolarization in Healthy Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol